The integration of cytokines into stem cell and organoid research has significantly advanced drug discovery by enabling more ...

ImmunityBio, Inc. , a leading immunotherapy company, today announced the U.S. Food and Drug Administration (FDA) has authorized an expanded access program (EAP) that will bring a vital alternative ...

As a biologics CDMO focused on developing and manufacturing recombinant protein products using mammalian cell culture ...

Researchers have discovered the mechanism that helps regulate the immune system’s response to helminth infection.